Literature DB >> 2742829

DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.

N Sheibani1, M M Jennerwein, A Eastman.   

Abstract

cis-Diamminedichloroplatinum(II) (cis-DDP) has a broad clinical application as an effective anticancer drug. However, development of resistance to the cytotoxic effects is a limiting factor. In an attempt to understand the mechanism of resistance, we have employed a host cell reactivation assay of DNA repair using a cis-DDP-damaged plasmid vector. The efficiency of DNA repair was assayed by measuring the activity of an enzyme coded for by the plasmid vector. The plasmid expression vector pRSVcat contains the bacterial gene coding for chloramphenicol acetyltransferase (CAT) in a configuration which permits expression in mammalian cells. The plasmid was transfected into repair-proficient and -deficient Chinese hamster ovary cells, and CAT activity was subsequently measured in cell lysates. In the repair-deficient cells, one cis-DDP adduct per cat gene was sufficient to eliminate expression. An equivalent inhibition of CAT expression in the repair-proficient cells did not occur until about 8 times the amount of damage was introduced into the plasmid. These results implicate DNA intrastrand cross-links as the lesions responsible for the inhibition of CAT expression. This assay was used to investigate the potential role of DNA repair in mediating cis-DDP resistance in murine leukemia L1210 cells. The parent cell line L1210/0 resembled repair-deficient cells in that about one adduct per cat gene eliminated expression. In three resistant L1210 cell lines, 3-6-fold higher levels of damage were required to produce an equivalent inhibition. This did not correlate with the degree of resistance as these cells varied from 10- to 100-fold resistant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742829     DOI: 10.1021/bi00433a055

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

Authors:  R J Parker; A Eastman; F Bostick-Bruton; E Reed
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

2.  A polymerase chain reaction-based method to detect cisplatin adducts in specific genes.

Authors:  M M Jennerwein; A Eastman
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

Review 3.  Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.

Authors:  P Calsou; B Salles
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.

Authors:  J N Burstyn; W J Heiger-Bernays; S M Cohen; S J Lippard
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA.

Authors:  C C Chao; S L Huang; H M Huang; S Lin-Chao
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II).

Authors:  J Hansson; R D Wood
Journal:  Nucleic Acids Res       Date:  1989-10-25       Impact factor: 16.971

7.  Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation.

Authors:  C C Chao
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs.

Authors:  M Alaoui-Jamali; B B Loubaba; S Robyn; H Tapiero; G Batist
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  In vivo damage and recA-dependent repair of plasmid and chromosomal DNA in the radiation-resistant bacterium Deinococcus radiodurans.

Authors:  M J Daly; L Ouyang; P Fuchs; K W Minton
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

10.  Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

Authors:  M Dabholkar; J Vionnet; F Bostick-Bruton; J J Yu; E Reed
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.